Results 171 to 180 of about 756,649 (382)

The role of ¹⁸F-FDG PET/CT in primary cutaneous lymphoma: an educational review. [PDF]

Ann Nucl Med, 2023
McDonald EO, Amanullah AA, Park PSU, Song W, Werner TJ, Alavi A, Revheim ME.   +6 more
europepmc   +1 more source

METTL3 Promotes Cutaneous T-Cell Lymphoma Progression by Regulating ARHGEF12 Expression [PDF]

Lu Gan, Yuanyuan Kong, Haoze Shi, Congcong Zhang, Cuicui Tian, Hao Chen   +5 more
openalex   +1 more source

Recent trends of incidence and mortality of cutaneous lymphomas in Germany

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background Primary cutaneous lymphomas (PCL) are primarily composed of cutaneous T‐cell lymphomas (CTCL), followed by cutaneous B‐cell lymphomas (CBCL). This study aimed to assess the incidence and survival rates of PCL in Germany. Methods We analyzed data from the North Rhine‐Westphalia Cancer Registry (2008–2021), which covers a population of
Khodr Cheikh El Najjarine, Hiltraud Kajüter, Ina Wellmann, Andreas Stang, Chalid Assaf   +4 more
wiley   +1 more source

Cutaneous Metastasis in Patient With Relapse Case of Primary Testicular Lymphoma

Clinical Case Reports
Non‐Hodgkin's lymphoma originates in the lymphatic system, specifically affecting B or T lymphocytes. Non‐Hodgkin's lymphoma of the testis is highly aggressive extranodal lymphoma originating from the testicles, constituting 1%–2% of all non‐Hodgkin's ...
Mahesh Mathur, Sumit Paudel, Sambidha Karki, Sandhya Regmi, Shilpa Maharjan, Nabita Bhattarai   +5 more
doaj   +1 more source

Acute Generalized Exanthematous Pustulosis in a Setting of Cutaneous Lymphoma. [PDF]

Cureus, 2022
Budh DP, Hawa S, Rios D, Chilakala A, Paniagua JA.   +4 more
europepmc   +1 more source

A study of activation antigens involved in the pathological mechanisms and pathways of cutaneous malignant disease with particular emphasis on cutaneous T cell lymphoma and malignant melanoma [PDF]

, 2010
The investigation of dermatological conditions embraces the concept of a clinicopathological correlation. The studies into cutaneous T cell lymphoma (CTCL) and malignant melanoma (MM), presented here involved predominantly immunocytochemical procedures
Orchard, G.R., Orchard, G.R.
core  

Combinatorial targeting of MYC/BCL2‐associated vulnerabilities in high‐grade B‐cell lymphoma

British Journal of Haematology, EarlyView.
Giulio Donati, Paola Nicoli, Federica Miele, Paola Podini, Giorgia Dina, Angelo Quattrini, Bruno Amati   +6 more
wiley   +1 more source

Neoadjuvant therapy in skin cancer: current evidence and future perspectives

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary The development of immune checkpoint inhibitors and targeted therapies has fundamentally changed the treatment of cutaneous malignancies, especially in squamous cell carcinoma, melanoma, and Merkel cell carcinoma. The latest neoadjuvant approaches have shown promising results in locally advanced stages.
Lea Daniello, Johannes Kleemann, Bastian Schilling   +2 more
wiley   +1 more source

Clinical efficacy of recombinant canine interferon‐gamma therapy in dogs with cutaneous epitheliotropic T‐cell lymphoma [PDF]

, 2023
Tomoya Hoshino, Nobuo Murayama, Yamagishi Kentaro, Yoshitoshi Okado, Haruaki Iwai, Ken Shirai, Soshi Hosaka, Peter F. Moore, Masahiko Nagata   +8 more
openalex   +1 more source

Defensive medicine in dermatological practice – Dermatopathology as a mirror of structural challenges

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Defensive medicine refers to diagnostic or therapeutic actions taken primarily to reduce legal liability rather than to benefit the patient. In dermatopathology, defensive practices manifest in frequent immunohistochemical testing, overly cautious report phrasing, and reliance on multidisciplinary tumor boards.
Cornelia Sigrid Lissi Müller, Torsten Hansen, Claus Renzelmann   +2 more
wiley   +1 more source